← SynDRA
EPZ-020411
SynDRA canonical compound SYN0062924 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | PRMT6 |
|---|
| Mechanism of action | protein arginine N-methyltransferase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- PRMT6 INHIBITOR
- protein arginine N-methyltransferase inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- BAZ2B
- CBX1
- CGA
- GBA1
- GLP1R
- HDAC6
- KDM4A
- TDP1
- TP53
- TRHR
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- 49L
- CS-5006
- EPZ020411
- HY-12970
- N,N'-dimethyl-N-({3-[4-({trans-3-[2-(tetrahydro-2H-pyran-4-yl)ethoxy]cyclobutyl}oxy)phenyl]-1H-pyrazol-4-yl}methyl)ethane-1,2-diamine
- SB19030
- AC-36052
- DA-73164
- SCHEMBL19432274
- EBC-415113
- orb1984332
- EX-A1601
- NSC790865
- SCHEMBL29426629
- Epz020411
- NCGC00482383-01
- BRD-K33586289-003-01-0
- BRD-K33586289-003-02-8
- EPZ020411 HCl?
- GLXC-10335
- NSC-790865
- NCGC00482383-02
- RefChem:137436
- GTPL9243
- AS-85932
- AKOS030526647
- MFCD28963945
- SCHEMBL17621957
Look up EPZ-020411 in the interactive SynDRA portal →